April Jobs Report Preview Labor Market Cooling But Showing Resilience Amid Challenges Brent Crude Above 100 Signals Persistent Tightness in 2026 JPMorgan Warns Vermont SelfStorage Operators See Boom Amid Housing Crunch and Aging Demographics Endurance Technologies IPO Concludes A Look Back at the Public Offering Delivery Hero Shares Surge 10 After Ubers 33perShare Takeover Bid Confirmed Intuit to Cut 17 of Workforce Amid AI Focus Shares Sink 42 in 2026 Inside Huaweis Chip Comeback The Woman Leading the Charge Against US Sanctions Retailers Navigate KShaped Economy With Price Cuts and Premiumization Strategies US Gasoline Demand Expected to Rise as Summer Travel Season Begins Potentially Adding Price Pressure Harikanta Overseas IPO Day 4 Subscription Crosses 50 as SME Offer Gains Traction Rush Street Interactive RSI Q1 2026 Earnings EPS Beats Estimates by 165 Stock Declines Slightly Selective Insurance Group Q1 2026 Earnings EPS Falls Short of Estimates IDEX Corporation Q1 2026 Earnings EPS Surpasses Estimates by 117 RRGB Q1 2026 Earnings Surprise Profit Beats Estimates by a Wide Margin VLYPN Q1 2026 Earnings Preferred Stock EPS Beats Estimates by 507 BSAC Q1 2026 Earnings EPS Surpasses Estimates Shares Rally on Strong Performance Hyliion Holdings Corp HYLN Surges 5 Testing Key Resistance at 728 Astera Labs ALAB Surges 3 Bulls Eye Key Resistance at 322 Amid AIDriven Momentum Guardian Metal Resources PLC GMTL Faces Selling Pressure Tests Key Support Levels Vita Coco Company COCO Advances 27 as Bullish Momentum Builds Opera Limited OPRA Edges Lower Amid Consolidation Near Resistance MannKind Corporation MNKD Slips 419 Testing 293 Support 20260515 Berkshire Hathaway Rebuilds Airline Exposure with 26 Billion Delta Air Lines Stake Bill BILL Q1 2026 Earnings Surprise EPS 068 Up Significant Wolverine WWW Gained 085 Can It Break 1612 20260515 Quartzsea QSEA Stalls at 1045 Consolidation Phase 20260515 Eli Lilly Stock Ticks Up on Plans for Nearly 4 Billion in VaccineRelated Deals XCUR Q2 2022 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue Adamas Trust Senior Notes ADAMO Hold Steady Near 2528 Amid Low Volatility